文献
J-GLOBAL ID:202102260895667873
整理番号:21A0071027
トリメブチンは高度糖化最終産物炎症性シグナル伝達経路のための高移動度グループボックス1受容体を減弱する【JST・京大機械翻訳】
Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways
著者 (18件):
Nakajima Shingo
(Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, 278-8510, Japan)
,
Ogawa Natsumi
(Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, 278-8510, Japan)
,
Yokoue Natsuki
(Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, 278-8510, Japan)
,
Tachibana Haruki
(Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, 278-8510, Japan)
,
Tamada Kenya
(Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, 278-8510, Japan)
,
Okazawa Miwa
(Department of Genomic Medicinal Science, Research Institute for Science and Technology, Organization for Research Advancement, Tokyo University of Science, Noda, Chiba, 278-8510, Japan)
,
Sato Akira
(Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, 278-8510, Japan)
,
Oyama Takahiro
(Hinoki Shinyaku Co. Ltd., Chiyoda-ku, Tokyo, 102-0084, Japan)
,
Abe Hideaki
(Hinoki Shinyaku Co. Ltd., Chiyoda-ku, Tokyo, 102-0084, Japan)
,
Kamiya Takanori
(Hinoki Shinyaku Co. Ltd., Chiyoda-ku, Tokyo, 102-0084, Japan)
,
Yoshimori Atsushi
(Institute for Theoretical Medicine Inc., Fujisawa, Kanagawa, 251-0012, Japan)
,
Yoshizawa Kazumi
(Laboratory of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, 278-8510, Japan)
,
Inoue Shigeaki
(Department of Emergency and Critical Care Medicine, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan)
,
Yokomizo Takehiko
(Department of Biochemistry, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, 113-8421, Japan)
,
Uchiumi Fumiaki
(Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, 278-8510, Japan)
,
Abe Takehiko
(Hinoki Shinyaku Co. Ltd., Chiyoda-ku, Tokyo, 102-0084, Japan)
,
Tanuma Sei-ichi
(Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, 278-8510, Japan)
,
Tanuma Sei-ichi
(Department of Genomic Medicinal Science, Research Institute for Science and Technology, Organization for Research Advancement, Tokyo University of Science, Noda, Chiba, 278-8510, Japan)
資料名:
Biochemical and Biophysical Research Communications
(Biochemical and Biophysical Research Communications)
巻:
533
号:
4
ページ:
1155-1161
発行年:
2020年
JST資料番号:
B0118A
ISSN:
0006-291X
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
オランダ (NLD)
言語:
英語 (EN)